DRUG
MECHANISM
USE
SIGNATURE TOXICITY
Ciprofloxacin · levofloxacin · moxifloxacin
DNA gyrase (gram −) and topoisomerase IV (gram +) inhibition
UTI, prostatitis, Pseudomonas (cipro), pneumonia (levo/moxi), anthrax
Tendon rupture, QT, aortic dissection, seizures, glucose swings, myasthenia flare
Metronidazole · tinidazole
Reduced in anaerobes → free radicals break DNA
Anaerobes below diaphragm, BV, trichomonas, giardia, amebiasis, C. difficile
Disulfiram reaction, metallic taste, neuropathy; ↑ warfarin
Sequential folate blockade (DHPS + DHFR)
UTI, PJP, toxoplasmosis prophylaxis, MRSA skin, Nocardia, Isospora
SJS, hyperkalemia, ↑ creatinine, hemolysis (G6PD), marrow suppression, kernicterus
Reactive intermediates damage DNA and ribosomes
Uncomplicated cystitis (incl. pregnancy before term)
Pulmonary fibrosis, neuropathy, hemolysis; avoid if CrCl < 30
Rifampin · rifabutin · rifapentine
Blocks bacterial DNA-dependent RNA polymerase
TB, latent TB (4 months), MRSA adjunct, meningococcal/Hib prophylaxis
Orange body fluids, hepatitis, potent CYP inducer; rapid resistance alone
Prodrug activated by KatG → ↓ mycolic acid synthesis
TB, latent TB
Hepatitis, peripheral neuropathy (give B6), drug-induced lupus, sideroblastic anemia, seizures in overdose (give B6)
Active at acidic pH (macrophages)
First 2 months of TB therapy
Hepatotoxicity, hyperuricemia (gout)
Blocks arabinosyltransferase (cell wall)
TB until susceptibility known
Optic neuritis — red-green color loss, ↓ acuity
Bedaquiline · pretomanid · linezolid
ATP synthase · cell wall/NO · protein synthesis
MDR/XDR TB
QT (bedaquiline), neuropathy, marrow
Clarithromycin/azithromycin + ethambutol ± rifabutin
MAC infection; azithromycin prophylaxis when CD4 < 50 (if not on ART)
Rifabutin uveitis
Dapsone (folate), rifampin, clofazimine
Tuberculoid and lepromatous leprosy
Dapsone hemolysis, methemoglobinemia; clofazimine skin discoloration
Isoniazid + rifapentine weekly (3 mo), rifampin (4 mo), or isoniazid (6–9 mo)
Positive TST/IGRA, normal CXR
Rule out active disease first